May 12, 2026
Polycystic Ovary Syndrome Renamed to Polyendocrine Metabolic Ovarian Syndrome After Global Consensus
After more than a decade of discussion, polycystic ovary syndrome (PCOS) has been officially renamed polyendocrine metabolic ovarian syndrome (PMOS) through a global consensus process involving patients and clinicians. The change affects a condition impacting approximately 170 million women worldwide and is expected to improve diagnosis and treatment.
8 sources
00